Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Intra-articular Multiple Doses of 500 µg Icatibant Including 40 mg Triamcinolone as Calibrator in a Randomized, Double-blind, Parallel-group, Placebo-controlled 13-week Multi-centre Study in Patients With Symptomatic Knee Osteoarthritis

NCT00303056 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00303056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00303056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Intra-articular Multiple Doses of 500 µg Icatibant Including 40 mg Triamcinolone as Calibrator in a Randomized, Double-blind, Parallel-group, Placebo-controlled 13-week Multi-centre Study in Patients With Symptomatic Knee Osteoarthritis
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2006
Completion date
July 31, 2007
Enrollment
590 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

joint disease